Niosomal tannic acid drug delivery system: An efficient strategy against vancomycin-intermediate Staphylococcus aureus (VISA) infections

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 19

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_NAMJ-11-3_008

تاریخ نمایه سازی: 11 تیر 1403

چکیده مقاله:

Objective(s): Our study aimed to formulate a niosomal system for enhancing tannic acid’s antibacterial and antibiofilm activities against vancomycin-intermediate staphylococcus aureus (VISA). Materials and Methods: Niosomal tannic acid was formulated by the thin-film hydration technique, which their physicochemical attributes, including drug loading, particle size, zeta potential, morphology, encapsulation efficiency (EE%), polydispersity index (PDI), release profile, were evaluated. To investigate the cell viability of the prepared niosomes, the cytotoxicity effect was analyzed against the human foreskin fibroblast (HFF) cell line. Finally, the antibacterial and anti-biofilm activities of niosomal formulation were examined against VISA strains and compared tothe free drug.Results: Scanning electron microscopy images showed that the niosomal formulation incorporated tannic acid was homogeneous, spherical, and identical in size (۱۵۱.۹ nm). EE% and surface charge of the synthesized niosomes were ۶۸.۹۰% and -۶۰ mV, respectively. The tannic acid-encapsulated niosomes showed a significant antibacterial potential in comparison with the free drug. Furthermore, niosomal tannic acid reduced the biofilm formation ability in all VISA strains and efficiently eradicated the formed bacterial biofilms at the same concentrations of the free drug.Conclusion: Niosomes, as vesicular-based nanoparticles, are known to be potent drug delivery vehicles due to numerous features such as non-toxicity, small size, sustained-release profile, and protection from pharmaceutical degradation. Niosomes have a high capacity to deliver wide range of antimicrobial agents, including natural compounds, which could be presented as a novel approach against bacterial infections, particularly VISA strains.Objective(s): Our study aimed to formulate a niosomal system for enhancing tannic acid’s antibacterial and antibiofilm activities against vancomycin-intermediate staphylococcus aureus (VISA). Materials and Methods: Niosomal tannic acid was formulated by the thin-film hydration technique, which their physicochemical attributes, including drug loading, particle size, zeta potential, morphology, encapsulation efficiency (EE%), polydispersity index (PDI), release profile, were evaluated. To investigate the cell viability of the prepared niosomes, the cytotoxicity effect was analyzed against the human foreskin fibroblast (HFF) cell line. Finally, the antibacterial and anti-biofilm activities of niosomal formulation were examined against VISA strains and compared tothe free drug.Results: Scanning electron microscopy images showed that the niosomal formulation incorporated tannic acid was homogeneous, spherical, and identical in size (۱۵۱.۹ nm). EE% and surface charge of the synthesized niosomes were ۶۸.۹۰% and -۶۰ mV, respectively. The tannic acid-encapsulated niosomes showed a significant antibacterial potential in comparison with the free drug. Furthermore, niosomal tannic acid reduced the biofilm formation ability in all VISA strains and efficiently eradicated the formed bacterial biofilms at the same concentrations of the free drug.Conclusion: Niosomes, as vesicular-based nanoparticles, are known to be potent drug delivery vehicles due to numerous features such as non-toxicity, small size, sustained-release profile, and protection from pharmaceutical degradation. Niosomes have a high capacity to deliver wide range of antimicrobial agents, including natural compounds, which could be presented as a novel approach against bacterial infections, particularly VISA strains.

کلیدواژه ها:

Biofilm ، Drug Delivery ، Niosome ، tannic acid ، Vancomycin-intermediate Staphylococcus aureus (VISA)

نویسندگان

Jaber Hemmati

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Mohsen Chiani

Department of NanoBiotechnology, Pasteur Institute of Iran, Tehran, Iran

Babak Asghari

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Ghodratollah Roshanaei

Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

Sara Soleimani Asl

Anatomy Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Morvarid Shafiei

Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran

Mohammad Arabestani

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kyaw MH, Kern DM, Zhou S, Tunceli O, Jafri HS, ...
  • Nasaj M, Farmany A, Shokoohizadeh L, Jalilian FA, Mahjoub R, ...
  • Wady AF, Machado AL, Foggi CC, Zamperini CA, Zucolotto V, ...
  • Zhao G HC, Xue Y. In vitro evaluation of chitosan‐coated ...
  • Durymanov M KT, Lehmann SE, Reineke J. Exploiting passive nanomedicine ...
  • Jawad KH, Marzoog TR, Hasoon BA, Sulaiman GM, Jabir MS, ...
  • Zhu X, Liu C, Gao S, Lu Y, Chen Z, ...
  • Kranjec C, Morales Angeles D, Torrissen Mårli M, Fernández L, ...
  • Kakoullis L, Papachristodoulou E, Chra P, Panos G. Mechanisms of ...
  • Raeiszadeh M, Pardakhty A, Sharififar F, Farsinejad A, Mehrabani M, ...
  • Rezaeiroshan A, Saeedi M, Morteza-Semnani K, Akbari J, Hedayatizadeh-Omran A, ...
  • Pardakhty A, Moazeni E. Nano-niosomes in drug, vaccine and gene ...
  • Lee MK. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In ...
  • Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective ...
  • Jain S, Jain V, Mahajan S. Lipid based vesicular drug ...
  • Aelenei N, Popa MI, Novac O, Lisa G, Balaita L. ...
  • Dabbaghi A, Kabiri K, Ramazani A, Zohuriaan‐Mehr MJ, Jahandideh A. ...
  • Lau S, Wahn J, Schulz G, Sommerfeld C, Wahn U. ...
  • Nonaka G-i, Nishioka I, Nishizawa M, Yamagishi T, Kashiwada Y, ...
  • Kaczmarek B. Tannic acid with antiviral and antibacterial activity as ...
  • Funatogawa K, Hayashi S, Shimomura H, Yoshida T, Hatano T, ...
  • Chung KT, Jr SS, Lin WF, Wei C. Growth inhibition ...
  • Kyaw BM, Arora S, Lim CS. Anti-Pseudomonal and anti-biofilm activity ...
  • Belhaoues S, Amri S, Bensouilah M. Major phenolic compounds, antioxidant ...
  • Akiyama H, Fujii K, Yamasaki O, Oono T, Iwatsuki K. ...
  • Mehrarya M, Gharehchelou B, Haghighi Poodeh S, Jamshidifar E, Karimifard ...
  • Ghafelehbashi R, Akbarzadeh I, Tavakkoli Yaraki M, Lajevardi A, Fatemizadeh ...
  • Hemmati J, Chegini Z, Arabestani MR. Niosomal-based drug delivery platforms: ...
  • Del AK, Kaboosi H, Jamalli A, Ghadikolaii FP. Prevalence and ...
  • Khan R, Irchhaiya R. Niosomes: a potential tool for novel ...
  • Zafari M, Adibi M, Chiani M, Bolourchi N, Barzi SM, ...
  • Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, ...
  • WS R. Imagej, us national institutes of health, bethesda, maryland, ...
  • Heidari F, Akbarzadeh I, Nourouzian D, Mirzaie A, Bakhshandeh H. ...
  • Blainski A, Lopes GC, De Mello JCP. Application and analysis ...
  • Sahiner N, Sagbas S, Aktas N, Silan C. Inherently antioxidant ...
  • Ali H, Shirode AB, Sylvester PW, Nazzal S. Preparation, characterization, ...
  • Thornsberry C. Antimicrobial susceptibility testing of anaerobic bacteria: review and ...
  • Barani M, Mirzaei M, Torkzadeh-Mahani M, Adeli-Sardou M. Evaluation of ...
  • Mirzaei R, Alikhani MY, Arciola CR, Sedighi I, Yousefimashouf R, ...
  • Aires-de-Sousa M. Methicillin-resistant Staphylococcus aureus among animals: Current overview. Clin ...
  • Awate PS, Pimple TP, Pananchery JF, Jain AS. Formulation and ...
  • Shadvar P, Mirzaie A, Yazdani S. Fabrication and optimization of ...
  • Dwivedi A, Mazumder A, Nasongkla N. Layer-by-layer nanocoating of antibacterial ...
  • Satish J, Amusa AS, Gopalakrishna P. In vitro activities of ...
  • Stan D, Enciu A-M, Mateescu AL, Ion AC, Brezeanu AC, ...
  • Shishir MRI, Taip FS, Saifullah M, Aziz NA, Talib RA. ...
  • Shishir MRI, Xie L, Sun C, Zheng X, Chen W. ...
  • Tabatabai MB, Mirjalili M, Yazdiyan F, Hekmatimoghaddam S. Antibacterial activity ...
  • Yadav, G. and Jain, A. ۱۱۲ Design and development of ...
  • Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, ...
  • Najafloo R, Baheiraei N, Imani R. Synthesis and characterization of ...
  • Gugleva V, Michailova V, Mihaylova R, Momekov G, Zaharieva MM, ...
  • Satish J, Amusa AS, Gopalakrishna P. In vitro activities of ...
  • Huang C-M, Chen C-H, Pornpattananangkul D, Zhang L, Chan M, ...
  • Kopermsub P, Mayen V, Warin C. Potential use of niosomes ...
  • Furneri PM, Fresta M, Puglisi G, Tempera G. Ofloxacin-loaded liposomes: ...
  • Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. ...
  • Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. ...
  • Barakat HS, Kassem MA, El-Khordagui LK, Khalafallah NM. Vancomycin-eluting niosomes: ...
  • Nejadnik MR, van der Mei HC, Norde W, Busscher HJ. ...
  • Banerjee I, Pangule RC, Kane RS. Antifouling coatings: recent developments ...
  • Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related ...
  • Neopane P, Nepal HP, Shrestha R, Uehara O, Abiko Y. ...
  • Kashef MT, Saleh NM, Assar NH, Ramadan MA. The antimicrobial ...
  • Soltani M, Hajikhani B, Zamani S, Haghighi M, Hashemi A, ...
  • Hemmati J, Azizi M, Asghari B, Arabestani MR. Multidrug-Resistant Pathogens ...
  • نمایش کامل مراجع